FindTrial
Sign In

Perioperative coagulation abnormalities in patients undergoing HIPEC surgery

Perioperative coagulopathy in patients undergoing cytoreductive surgery and heated intraperitoneal chemotherapy - nil

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2023/10/058904
Enrollment
43
Registered
2023-10-19
Start date
Unknown
Completion date
Unknown
Last updated
2023-11-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C569- Malignant neoplasm of unspecifiedovary

Interventions

Intervention1: nil: nil

Sponsors

Malabar cancer centre
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: patients undergoing CRS and HIPEC patients >18 years and <80 years

Exclusion criteria

Exclusion criteria: patients undergoing CRS not proceeding for HIPEC

Design outcomes

Primary

MeasureTime frame
To find out the incidence of perioperative coagulopathyTimepoint: preoperative and first five postoperative days—

Secondary

MeasureTime frame
to find out the factors affecting perioperative coagulopathy & to find out the incidence of postoperative thromboembolic complicationsTimepoint: 4 weeks—

Countries

India

Contacts

Public ContactDr Joona P

Malabar cancer centre

drjoonap@gmail.com9496651604

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026